VREOF
Vireo Growth Inc.
Key Financials
Gross Profit
$127.1M
↑ 150.3%
Revenue
$268.8M
↑ 170.4%
Operating Income
$-1048483
↓ 107.7%
Net Income
$-68113908
↓ 143.2%
EPS (Diluted)
$-0.09
↑ 43.8%
Total Assets
$817.2M
↑ 193.0%
Total Liabilities
$509.7M
↑ 128.3%
Shareholders' Equity
$307.4M
↑ 453.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 425 | 8/18/2026 | View on SEC |
| 8-K | 8/18/2026 | View on SEC |
| 425 | 8/18/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| 425 | 8/13/2026 | View on SEC |
| 425 | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 425 | 8/12/2026 | View on SEC |
| 425 | 8/11/2026 | View on SEC |
| 425 | 8/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VREOF |
| Company Name | Vireo Growth Inc. |
| CIK | 1771706 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | 604-617-5421 |